From October 1, 2023 to December 31, 2023, the company has repurchased 811,384 shares, representing 1.29% for $99.79 million. With this, the company has completed the repurchase of 9,991,026 shares, representing 16.77% for $1,358.79 million under the buyback announced on November 8, 2016.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
101.3 USD | -2.18% | -5.12% | -17.67% |
01/07 | Jazz Pharmaceuticals plc(NasdaqGS:JAZZ) dropped from Russell 3000E Growth Index | CI |
01/07 | Jazz Pharmaceuticals plc(NasdaqGS:JAZZ) dropped from Russell 1000 Growth Index | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.67% | 638.63Cr | |
+56.89% | 82TCr | |
+39.52% | 63TCr | |
-6.55% | 35TCr | |
+15.99% | 32TCr | |
+7.92% | 30TCr | |
+13.74% | 24TCr | |
+13.83% | 22TCr | |
-0.49% | 22TCr | |
+7.94% | 17TCr |
- Stock Market
- Equities
- JAZZ Stock
- News Jazz Pharmaceuticals plc
- Tranche Update on Jazz Pharmaceuticals plc's Equity Buyback Plan announced on November 8, 2016.